4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.46
+0.01 (0.11%)
At close: Apr 28, 2026, 4:00 PM EDT
9.42
-0.04 (-0.42%)
After-hours: Apr 28, 2026, 4:10 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $480.91 million as of April 28, 2026. Its market cap has increased by 301.01% in one year.
Market Cap
480.91M
Enterprise Value
-11.72M
1-Year Change
301.01%
Ranking
Category
Stock Price
$9.46
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $480.91M, a decrease of -17.14%. That is a compound annual growth rate of -3.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Upstream Bio | 506.11M |
| ADC Therapeutics | 501.13M |
| Candel Therapeutics | 476.11M |
| Armata Pharmaceuticals | 473.30M |
| Prelude Therapeutics | 472.60M |
| Larimar Therapeutics | 471.63M |
| Valneva SE | 470.89M |
| Aura Biosciences | 466.73M |